Aj
Ajax Ther
Boston MAFounded 202025 employees
Private CapbiotechPrivateOncology
Platform: Neoantigen
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Niranaritide | AJA-7035 | Phase 2/3 | 2 | USP1 | SMA | ||
| AJA-3524 | AJA-3524 | Phase 1/2 | 2 | FXIa | FTDPancreatic Ca | ||
| AJA-7822 | AJA-7822 | Phase 2 | 2 | IL-23 | PsAADHD | ||
| AJA-7840 | AJA-7840 | NDA/BLA | 2 | GPRC5D | RA |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)